Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANITA SABICHI and JAN KEMNADE.
ANITA SABICHI
Connection Strength
0.387
JAN KEMNADE
  1. Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
    View in: PubMed
    Score: 0.226
  2. Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes. Laryngoscope Investig Otolaryngol. 2023 Aug; 8(4):895-902.
    View in: PubMed
    Score: 0.056
  3. Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access. Cancer Res Commun. 2022 07 26; 2022.
    View in: PubMed
    Score: 0.053
  4. Non-small cell lung cancer in the era of immunotherapy. Semin Oncol. 2022 Jun; 49(3-4):337-343.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.